Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00570934 · ClinicalTrials.gov registry record · Phase 3
Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA
A Phase 3 study of Juvenile Rheumatoid Arthritis, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 3
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00570934 is a Phase 3 study of Juvenile Rheumatoid Arthritis that has completed, run by University of Missouri-Columbia. The registered enrollment target is 24 participants, below the 129-participant average among 3 other Juvenile Rheumatoid Arthritis trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00570934, a Phase 3 study of Juvenile Rheumatoid Arthritis, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
2000 international units (IU) vitamin D, 1 gram (gm) calcium, or both given to children with Juvenile Rheumatoid Arthritis (JRA) may increase percent true calcium absorption, bone mineral turnover and/or bone mineralization.
Conditions Studied
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT Cholecalciferol
- DIETARY_SUPPLEMENT Calcium
- DIETARY_SUPPLEMENT Calcium and cholecalciferol
Study Locations (1)
Missouri
- University of Missouri Hospitals and clinics - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 1995-03 |
| Est. Completion | 2002-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00570934
The ClinicalTrials.gov registry entry for NCT00570934 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 129-participant average among 3 other Juvenile Rheumatoid Arthritis trials with a reported enrollment target (81% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Juvenile Rheumatoid Arthritis appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT00570934 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT00570934 about?
NCT00570934 is a clinical study titled "Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA". 2000 international units (IU) vitamin D, 1 gram (gm) calcium, or both given to children with Juvenile Rheumatoid Arthritis (JRA) may increase percent true calcium absorption, bone mineral turnover and/or bone mineralization.
What is the current status of trial NCT00570934?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 24 participants. The study started on 1995-03. Estimated completion is 2002-02.
What conditions does trial NCT00570934 study?
This clinical trial studies the following conditions: Juvenile Rheumatoid Arthritis.
What interventions are being tested in trial NCT00570934?
The interventions under investigation include: Placebo (DRUG), Cholecalciferol (DIETARY_SUPPLEMENT), Calcium (DIETARY_SUPPLEMENT), Calcium and cholecalciferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00570934?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00570934 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Juvenile Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.